Long-Term Care

Leukemia drug found effective in treating MS

Contemporary Long-Term Care Weekly, October 30, 2008

In a recent study conducted by researchers at the University of Cambridge in England, alemtuzumab, a drug designed to treat chronic lymphocytic leukemia, reduced the effects of multiple sclerosis (MS) in participants, according to the results published in the October 23 issue of the New England Journal of Medicine.

Alemtuzumab reduced the number of attacks participants experienced by 74% over interferon beta-1a, the most effective drug currently used in the treatment of MS. Study results also reveal that participants taking alemtuzumab recovered some of their lost functions, leading researchers to believe that the drug allows for the recovery of damaged brain tissue.

Comments

0 comments on “Leukemia drug found effective in treating MS

 

Most Popular

Related Articles